Viewing Study NCT03002805


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-02-21 @ 8:04 AM
Study NCT ID: NCT03002805
Status: UNKNOWN
Last Update Posted: 2019-08-19
First Post: 2016-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin
Sponsor: CBA Research
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None CBT-1® View
None Doxorubicin View
None Sarcoma View